Position
Squarepoint Ops LLC in Neurocrine Biosciences Inc
Back to the book · All holders of NBIX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$2.12M$141.83 → $131.74
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 209.7K | $29.7M | — | — | — | 0.0% |
| Q1 2026 | 488K | $64.3M | $131.74 | −$2.12M | $36.7M | 0.1% |